Curian Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-64,037
Closed -$5.4M 222
2015
Q4
$5.4M Sell
64,037
-112,474
-64% -$9.33M 0.4% 44
2015
Q3
$14.8M Sell
176,511
-68,226
-28% -$5.76M 0.39% 47
2015
Q2
$20.4M Sell
244,737
-44,559
-15% -$3.4M 0.34% 62
2015
Q1
$21M Sell
289,296
-126,236
-30% -$8.99M 0.35% 57
2014
Q4
$28.7M Buy
415,532
+3,730
+0.9% +$252K 0.48% 43
2014
Q3
$26.7M Sell
411,802
-8,383
-2% -$531K 0.47% 43
2014
Q2
$26.1M Buy
420,185
+2,119
+0.5% +$126K 0.46% 45
2014
Q1
$24.6M Buy
418,066
+362,707
+655% +$20.2M 0.44% 40
2013
Q4
$2.82M Sell
55,359
-3,566
-6% -$179K 0.05% 236
2013
Q3
$2.97M Buy
58,925
+34,591
+142% +$1.81M 0.05% 228
2013
Q2
$1.2M Buy
+24,334
New +$1.32M 0.02% 327

Other funds holding LLY

Curian Capital's LLY Position: Q1 2016 in Review

Curian Capital sold out of Eli Lilly (LLY) in Q1 2016, closing a stake of 64,037 shares — an estimated $5.4M sold.

Curian Capital first reported a position in LLY in Q2 2013 and held it in 11 quarters. The position peaked at $28.7M in Q4 2014. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • Curian Capital reported no remaining Eli Lilly position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 64,037 Eli Lilly shares in Q1 2016, an estimated $5.4M.
  • Curian Capital first reported a position in Eli Lilly in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Eli Lilly position peaked at $28.7M in Q4 2014.
  • 1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.